Loading clinical trials...

Continuous Glucose Monitoring System: Accuracy and Prognostic Value in Critically Ill Patients | Clinical Trials | Clareo Health

ENROLLING_BY_INVITATION

Continuous Glucose Monitoring System: Accuracy and Prognostic Value in Critically Ill Patients

NCT07108179•Sinocare

View on ClinicalTrials.gov

Summary

Whether diabetic or non-diabetic patients, blood glucose management during ICU hospitalization is essential. This study aims to evaluate the accuracy of the iCan Continuous Glucose Monitoring (CGM) System for detecting blood glucose levels in ICU patients, as well as its value in prognostic evaluation, to provide reference for blood glucose management in critically ill patients.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•1. Age ≥ 18 years; gender not limited.
•2. Expected ICU (Intensive Care Unit) stay ≥ 48 hours.
•3. Patients requiring frequent blood gas monitoring in the ICU.

Exclusion Criteria

•1. The patient or their family refuses to use CGM for blood glucose monitoring.
•2. Patients with adverse skin conditions (such as rash, active inflammation, etc.) in the device placement area, or those requiring emergency surgical intervention in that area.
•3. Patients who need to undergo computed tomography (CT), X-ray, or magnetic resonance imaging (MRI) scans on the device placement area during the study period.

Locations (1)

Continuous glucose monitoring system

Changsha, changsha, China

Key Dates

Start Date

March 4, 2025

Primary Completion Date

August 1, 2025

Completion Date

September 1, 2025

Last Updated

August 6, 2025

Enrollment

120

ESTIMATED participants

Conditions

Critically Ill Patients

Interventions

Continuous Glucose Monitoring (CGM) System

DEVICE

Reaching a Caloric Goal Using a Gastric Sonar Versus Aspiration of Gastric Contents in Critically Ill Patients Receiving Nasogastric Enteral Nutrition

NCT06557629

Enteral Nutrition Intolerance in Critically Ill Patients

View study

RECRUITING

Secondary Sclerosis Cholangitis Prospective

NCT03566797

Secondary Sclerosis Cholangitis in Critically Ill Patients

View study

COMPLETED

Arterial Pressure Derived Dynamic Parameters to Detect Preload Responsiveness in Mechanically Ventilated Patients Under Spontaneous Mode

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 6, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Continuous Glucose Monitoring System: Accuracy and Prognostic Value in Critically Ill Patients

Inclusion Criteria

Exclusion Criteria

Reaching a Caloric Goal Using a Gastric Sonar Versus Aspiration of Gastric Contents in Critically Ill Patients Receiving Nasogastric Enteral Nutrition

Secondary Sclerosis Cholangitis Prospective

Arterial Pressure Derived Dynamic Parameters to Detect Preload Responsiveness in Mechanically Ventilated Patients Under Spontaneous Mode

Ultrasound for Confirmation of Gastric Tube Placement in Critically Ill Patients Under Invasive Mechanical Ventilation

Esketamine Induction Intubation in ICU Patients.

Fourth International Study of Mechanical Ventilation From VENTILA GROUP